Bristol-Myers Squibb CompanyBMY

NYSEHealthcarePharmaceuticals$59.08+0.22%

A global biopharmaceutical company focused on developing and commercializing prescription medicines for oncology, hematology, immunology, cardiovascular, and neuroscience diseases. Its portfolio includes blockbuster therapies such as Opdivo and Eliquis, which drive a significant share of revenue alongside a growing pipeline of biologics and specialty drugs. Investors track the company for patent expiration risks, pipeline development milestones, and capital allocation decisions that shape long-term earnings growth.

Market Cap: $120.3B52W Range: $42.52 – $62.89

Congressional Interest in Bristol-Myers Squibb Company (BMY)

9 members of Congress have disclosed 22 trades in Bristol-Myers Squibb Company (BMY), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.